Cite
HARVARD Citation
Zhao, M. et al. (n.d.). P405 Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease – preliminary results from the Danish IBD Biobank Project. Journal of Crohn's and colitis. pp. i397-i398. [Online].